Search results
3 Reasons to Buy AbbVie Stock on the Dip
Motley Fool via Yahoo Finance· 3 hours ago*Stock Advisor returns as of April 30, 2024 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and...
Investors Take AbbVie To The Woodshed. But Its Woes Are 'Unfounded.'Investors Take AbbVie To The...
Investor's Business Daily· 6 days agoOn Friday, AbbVie beat first-quarter expectations, largely on the back of its immunology franchise....
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 2 days agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoBy leveraging its strengths and addressing its weaknesses, AbbVie can capitalize on opportunities and mitigate threats, positioning itself for continued...
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoAbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 4 days agoThis is why empirical research shows a strong correlation between trends in earnings estimate...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 4 days agoBarclays‘s target price would suggest a potential upside of 14.94% from the company’s previous close. Several other equities research analysts have also recently commented on ABBV. BMO Capital ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. < ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 6 days agoA number of other analysts have also recently weighed in on the company. Truist Financial raised their price objective on AbbVie from $180.00 to $195.00 and gave the
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 5 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
